These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2040 related items for PubMed ID: 27033342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F, Renlund H, Lip GY, Wester P, Svensson PJ, Själander A.
    JAMA Cardiol; 2016 May 01; 1(2):172-80. PubMed ID: 27437888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY, Lau WCY, Wong ICK, Lip GYH, Mok MT, Siu CW, Chan EW.
    J Am Coll Cardiol; 2018 Jul 17; 72(3):271-282. PubMed ID: 30012320
    [Abstract] [Full Text] [Related]

  • 7. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T, Kaneko H, Mishina S, Wang F, Morita S.
    J Stroke Cerebrovasc Dis; 2017 Oct 17; 26(10):2102-2110. PubMed ID: 28532651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC, Schnee J, Fraeman K, Siu K, Reynolds MW, Collins J, Schwartzman E.
    Thromb Haemost; 2015 Nov 25; 114(6):1290-8. PubMed ID: 26446456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX, Malo S, Svenson LW, Wilton SB, Hill MD.
    J Am Heart Assoc; 2017 Oct 28; 6(11):. PubMed ID: 29080863
    [Abstract] [Full Text] [Related]

  • 20. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
    Nelson WW, Desai S, Damaraju CV, Lu L, Fields LE, Wildgoose P, Schein JR.
    Am J Cardiovasc Drugs; 2015 Jun 28; 15(3):205-11. PubMed ID: 25944648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.